The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Utility of Anti–Melanoma Differentiation–Associated Gene 5 Antibody Measurement in Identifying Patients With Dermatomyositis and a High Risk for Developing Rapidly Progressive Interstitial Lung Disease: A Review of the Literature and a Meta‐Analysis
Abstract
Objective: To assess the utility of anti–melanoma differentiation–associated gene 5 (anti‐MDA5) antibody measurement for predicting a risk for developing rapidly progressive interstitial lung disease (RP‐ILD) in patients with polymyositis/dermatomyositis (PM/DM). Methods: A single‐center cohort of 64 consecutive Chinese patients with PM/DM was examined. Serum anti‐MDA5 antibody was measured by enzyme‐linked immunosorbent assay. For meta‐analysis, we searched PubMed and the Institute for Scientific Information Web of Knowledge for original studies that measured anti‐MDA5 antibodies in patients with PM/DM. We calculated pooled sensitivity, specificity, diagnostic odds ratio (DOR), and the summary receiver operating characteristic (sROC) curve. Results: In Chinese patients, anti‐MDA5 antibodies were detected in 26 patients with classic DM or clinically amyopathic DM (CADM). Compared with anti‐MDA5–negative patients, anti‐MDA5–positive patients showed a higher prevalence of RP‐ILD (P = 0.001). In a total of 233 patients with anti‐MDA5 antibody, derived from 16 studies, a higher frequency of CADM was found in Japanese than in non‐Japanese patients (74.7% versus 39.2%; P = 1.2 × 10−7). Meta‐analysis revealed that the pooled sensitivity and specificity of anti‐MDA5 antibody for RP‐ILD was 77% (95% confidence interval [95% CI] 64–87%) and 86% (95% CI 79–90%), respectively. The pooled DOR was 20.41 (95% CI 9.02–46.20) with a favorable area under the sROC curve of 0.89 (95% CI 0.63–0.98). Conclusion: Detection of anti‐MDA5 antibody is a valuable tool for identifying DM patients with a high risk for developing RP‐ILD, but the distribution of classic DM and CADM in patients with this antibody varies among ethnic groups.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186
Polymyositis and Dermatomyositis: (First of Two Parts)
Bohan, A., & Peter, J. B. (1975) · New England Journal of Medicine · doi:10.1056/nejm197502132920706 · Cited by 5,059
Reitsma, J. B., Glas, A. S., Rutjes, A. W. S., Scholten, R. J. P. M., Bossuyt, P. M., & Zwinderman, A. H. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.02.022 · Cited by 3,369
Deeks, J. J., Macaskill, P., & Irwig, L. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2005.01.016 · Cited by 2,910
Polymyositis and Dermatomyositis: (Second of Two Parts)
Bohan, A., & Peter, J. B. (1975) · New England Journal of Medicine · doi:10.1056/nejm197502202920807 · Cited by 2,447
Meta-DiSc: a software for meta-analysis of test accuracy data
Zamora, J., Abraira, V., Muriel, A., Khan, K., & Coomarasamy, A. (2006) · BMC Medical Research Methodology · doi:10.1186/1471-2288-6-31 · Cited by 1,883
Sato, S., Hirakata, M., Kuwana, M., Suwa, A., Inada, S., Mimori, T., Nishikawa, T., Oddis, C. V., & Ikeda, Y. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21023 · Cited by 747
Self-citationSato, S., Hoshino, K., Satoh, T., Fujita, T., Kawakami, Y., Fujita, T., & Kuwana, M. (2009) · Arthritis & Rheumatism · doi:10.1002/art.24621 · Cited by 604
Self-citationFiorentino, D., Chung, L., Zwerner, J., Rosen, A., & Casciola-Rosen, L. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.09.016 · Cited by 554
Troyanov, Y., Targoff, I. N., Tremblay, J.-L., Goulet, J.-R., Raymond, Y., & Senécal, J.-L. (2005) · Medicine · doi:10.1097/01.md.0000173991.74008.b0 · Cited by 506
Gono, T., Sato, S., Kawaguchi, Y., Kuwana, M., Hanaoka, M., Katsumata, Y., Takagi, K., Baba, S., Okamoto, Y., Ota, Y., et al. (2012) · Rheumatology · doi:10.1093/rheumatology/kes102 · Cited by 339
Self-citationNakashima, R., Imura, Y., Kobayashi, S., Yukawa, N., Yoshifuji, H., Nojima, T., Kawabata, D., Ohmura, K., Usui, T., Fujii, T., et al. (2010) · Rheumatology · doi:10.1093/rheumatology/kep375 · Cited by 334
Hamaguchi, Y., Kuwana, M., Hoshino, K., Hasegawa, M., Kaji, K., Matsushita, T., Komura, K., Nakamura, M., Kodera, M., Suga, N., et al. (2011) · Archives of Dermatology · doi:10.1001/archdermatol.2011.52 · Cited by 333
Self-citationGono, T., Kawaguchi, Y., Satoh, T., Kuwana, M., Katsumata, Y., Takagi, K., Masuda, I., Tochimoto, A., Baba, S., Okamoto, Y., et al. (2010) · Rheumatology · doi:10.1093/rheumatology/keq149 · Cited by 319
Self-citationAnti-MDA5 and anti-TIF1-γ antibodies have clinical significance for patients with dermatomyositis
Hoshino, K., Muro, Y., Sugiura, K., Tomita, Y., Nakashima, R., & Mimori, T. (2010) · Rheumatology · doi:10.1093/rheumatology/keq153 · Cited by 260
Mukae, H., Ishimoto, H., Sakamoto, N., Hara, S., Kakugawa, T., Nakayama, S., Ishimatsu, Y., Kawakami, A., Eguchi, K., & Kohno, S. (2009) · Chest · doi:10.1378/chest.08-2740 · Cited by 203
Cao, H., Pan, M., Kang, Y., Xia, Q., Li, X., Zhao, X., Shi, R., Lou, J., Zhou, M., Kuwana, M., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21728 · Cited by 187
Self-citationDermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis
Mammen, A. L. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05119.x · Cited by 186
Sato, S., Kuwana, M., Fujita, T., & Suzuki, Y. (2012) · Modern Rheumatology · doi:10.1007/s10165-012-0663-4 · Cited by 175
Self-citationArnett, F. C., Targoff, I. N., Mimori, T., Goldstein, R., Warner, N. B., & Reveille, J. D. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390910 · Cited by 169
HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody
Tanizawa, K., Handa, T., Nakashima, R., Kubo, T., Hosono, Y., Watanabe, K., Aihara, K., Oga, T., Chin, K., Nagai, S., et al. (2011) · Respiratory Medicine · doi:10.1016/j.rmed.2011.05.006 · Cited by 138
Chinoy, H., Salway, F., Fertig, N., Shephard, N., Tait, B. D., Thomson, W., Isenberg, D. A., Oddis, C. V., Silman, A. J., Ollier, W., et al. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1862 · Cited by 132
Clinically amyopathic dermatomyositis
Sato, S., & Kuwana, M. (2010) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32833f1987 · Cited by 102
Self-citationKobayashi, I., Okura, Y., Yamada, M., Kawamura, N., Kuwana, M., & Ariga, T. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2010.11.033 · Cited by 98
Self-citationMuro, Y., Sugiura, K., Hoshino, K., Akiyama, M., & Tamakoshi, K. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3547 · Cited by 86
METANDI: Stata module to perform meta-analysis of diagnostic accuracy
Harbord, R. M. (2008) · RePEc: Research Papers in Economics · Cited by 31
Cited by
Myositis‐specific autoantibodies: an important tool to support diagnosis of myositis
Betteridge, Z., & McHugh, N. (2016) · Journal of Internal Medicine · doi:10.1111/joim.12451 · Cited by 1,056
Tsuji, H., Nakashima, R., Hosono, Y., Imura, Y., Yagita, M., Yoshifuji, H., Hirata, S., Nojima, T., Sugiyama, E., Hatta, K., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41105 · Cited by 357
Moghadam‐Kia, S., Oddis, C. V., Sato, S., Kuwana, M., & Aggarwal, R. (2016) · Arthritis Care & Research · doi:10.1002/acr.22728 · Cited by 277
Self-citationDermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies
Nombel, A., Fabien, N., & Coutant, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.773352 · Cited by 262
The Diagnosis and Treatment of Antisynthetase Syndrome
Witt, L. J., Curran, J. J., & Strek, M. E. (2016) · Clinical Pulmonary Medicine · doi:10.1097/cpm.0000000000000171 · Cited by 253
Metadata
- Authors
- Chen, Z., Cao, M., Plana, M. N., Liang, J., Cai, H., Kuwana, M., & Sun, L.
- Venue
- Arthritis Care & Research
- Publisher
- Wiley
- Published
- 2013-07-26
- Volume
- 65
- Issue
- 8
- Pages
- 1316-1324
- ISSN
- 0893-7524 (ISSN-L)
- 2151-464X
- 2151-4658
- OpenAlex
- W1479898381
- Cited by
- 288
- References
- 26
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.